Hisamitsu To Apply For Additional Indication Of Fentos Tape For Chronic Pain Treatment
This article was originally published in PharmAsia News
Executive Summary
Hisamitsu Pharmaceuticals plans to file an application for the additional indication of its transdermal, long-acting cancer pain relief patch Fentos Tape (fentanyl citrate) for chronic pain sometime this year.